BRIEF-Telix Pharmaceuticals Posts FY Net Income Of AUD 49.9 Million

Reuters
20 Feb
BRIEF-Telix Pharmaceuticals Posts FY Net Income Of AUD 49.9 Million

Feb 20 (Reuters) - Telix Pharmaceuticals Ltd FY adjusted EBITDA AUD 99.3 million.

  • FY revenue AUD 783.2 million
  • FY net income AUD 49.9 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10